Shoulder Board decisions

The Board denied the veteran's claims for increased ratings for his thoracolumbar spine, left and right shoulder disabilities, hypertension, and bilateral sensorineural hearing loss.

The Board denied service connection for an acquired psychiatric disorder, to include PTSD, and remanded claims for service connection for a left shoulder disorder, right knee disorder, and thoracic spine disorder.

The Board remands the claims for service connection for bilateral shin splints, cervical strain (claimed as neck strain), lumbosacral strain (claimed as lower back strain), left shoulder strain (claimed as painful joints), and right shoulder strain (claimed as painful joints) to obtain an adequate medical opinion.

The Board remands the case to schedule a VA examination to determine if the Veteran's preexisting right clavicle fracture was worsened by his active service.

The Board denied higher ratings for the Veteran's degenerative joint disease, radiculopathy of the right upper extremity, right shoulder rotator cuff tendonitis, angiolymphoid hyperplasia with eosinophilia, and pseudofolliculitis barbae.

The Board remands the claims for service connection for bilateral shoulder, hip and ankle conditions as well as a TDIU due to the need for additional medical opinions addressing secondary causation and aggravation.

The Board granted service connection for cervical spine degenerative disc disease and degenerative arthritis, right shoulder degenerative arthritis, left shoulder degenerative arthritis, and lumbosacral spine degenerative disc disease and degenerative arthritis. The claim for hypertension was denied.

The Board granted service connection for posttraumatic stress disorder (PTSD) and granted an initial separate and compensable disability rating of 10 percent, and no higher, for vertigo secondary to tinnitus. Other claims were denied.

The Board remands the claims for service connection for left hip, left shoulder, right shoulder, left knee, right hip, and right knee disabilities to obtain additional medical opinions.

The appeal was dismissed due to an impermissible concurrent election of review options.

The Board denied an initial compensable disability rating for left ocular hypertension and remanded the claims for service connection for a lower back condition and a right shoulder condition.

The veteran withdrew his appeals for service connection for various disabilities, including a cervical spine disability with residuals to the right upper extremity, a right shoulder disability, a left shoulder disability, posttraumatic stress disorder (PTSD), and a heart disability.

The Board denied service connection for right foot, left foot, left elbow, and right shoulder disabilities as there was no evidence linking these conditions to the Veteran's military service.

The Board has remanded the claims for further development of evidence, including obtaining additional VA medical records and private treatment records.

The Board denied the Veteran's appeal for an evaluation in excess of 10 percent for her service-connected right shoulder disability, as there was no evidence to support a higher rating.

The Board denied an initial compensable rating for allergic rhinitis and remanded the claims for service connection for a back, right ankle, and right shoulder disorder.

The Board denied service connection for a left shoulder disability and denied increased ratings for the service-connected left knee, left knee scar, and right knee disabilities. However, it granted a 60 percent rating for the service-connected left knee strain with degenerative arthritis status post total knee replacement.

The Board denied service connection for bilateral hearing loss and remanded claims for cervical spine, left shoulder, wrist, hip, knee, and upper extremity nerve disabilities due to insufficient evidence.

The Board granted service connection for a left knee disability and left and right shoulder disabilities, but denied service connection for right and left elbow disabilities.

The Board granted service connection for diabetes mellitus type II, related to in-service toxic exposure, effective August 10, 2022.